BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 21969911)

  • 21. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
    Sabater L; Titulaer M; Saiz A; Verschuuren J; Güre AO; Graus F
    Neurology; 2008 Mar; 70(12):924-8. PubMed ID: 18032743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paraneoplastic Cerebellar Degeneration and Lambert-Eaton Myasthenic Syndrome Associated with Neuroendocrine Carcinoma of the Oropharynx.
    Takasugi J; Shimamura M; Koda T; Kishikawa T; Hanamoto A; Inohara H; Sato K; Morii E; Motomura M; Sakaguchi M; Nakatsuji Y; Mochizuki H
    Intern Med; 2018 Feb; 57(4):587-590. PubMed ID: 29093415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute Respiratory Failure Resulting From Lambert-Eaton Myasthenic Syndrome: A Case Report and Literature Review.
    Spicer AR; Reyes CZA; Varade PM
    Cureus; 2024 May; 16(5):e59516. PubMed ID: 38826943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence of serum anti-P/O-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome.
    Motomura M; Lang B; Johnston I; Palace J; Vincent A; Newsom-Davis J
    J Neurol Sci; 1997 Mar; 147(1):35-42. PubMed ID: 9094058
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The action of Lambert-Eaton myasthenic syndrome immunoglobulin G on cloned human voltage-gated calcium channels.
    Pinto A; Iwasa K; Newland C; Newsom-Davis J; Lang B
    Muscle Nerve; 2002 May; 25(5):715-724. PubMed ID: 11994966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specificity of Lambert-Eaton myasthenic syndrome immunoglobulin for nerve terminal calcium channels.
    Hewett SJ; Atchison WD
    Brain Res; 1992 Dec; 599(2):324-32. PubMed ID: 1363289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lambert-Eaton Myasthenic syndrome: early diagnosis is key.
    Ivanovski T; Miralles F
    Degener Neurol Neuromuscul Dis; 2019; 9():27-37. PubMed ID: 31191084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relapse of both small cell lung cancer and Lambert-Eaton myasthenic syndrome after a 13-year disease-free survival period.
    Asano F; Watanabe K; Shinkai M; Tei Y; Mishina K; Tanabe M; Ishii H; Shinoda M; Shimokawaji T; Kudo M; Kaneko T
    Chin J Cancer; 2016 Jul; 35(1):63. PubMed ID: 27370896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A case of lambert-eaton myasthenic syndrome with small-cell lung cancer and transient increase in anti-acetylcholine-receptor-binding antibody titer.
    Lee JH; Shin HY; Kim SM; Sunwoo IN
    J Clin Neurol; 2012 Dec; 8(4):305-7. PubMed ID: 23323140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lambert-Eaton syndrome antibodies target multiple subunits of voltage-gated Ca2+ channels.
    Hajela RK; Huntoon KM; Atchison WD
    Muscle Nerve; 2015 Feb; 51(2):176-84. PubMed ID: 24862203
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteasome inhibitors for malignancy-related Lambert-Eaton myasthenic syndrome.
    Wang C; Chen S; Feng B; Guan Y
    Muscle Nerve; 2014 Mar; 49(3):325-8. PubMed ID: 24464710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amifampridine to treat Lambert-Eaton myasthenic syndrome.
    Oh SJ
    Drugs Today (Barc); 2020 Oct; 56(10):623-641. PubMed ID: 33185628
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lambert-Eaton myasthenic syndrome (LEMS)].
    Suzuki S
    Brain Nerve; 2010 Apr; 62(4):419-26. PubMed ID: 20420183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma lncRNA LOC338963 and mRNA AP3B2 are upregulated in paraneoplastic Lambert-Eaton myasthenic syndrome.
    Yang F; Jing F; Li Y; Kong S; Zhang S; Huo Y; Huang X; Yu S
    Muscle Nerve; 2022 Aug; 66(2):216-222. PubMed ID: 35508598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Unique Case of Non-paraneoplastic Lambert-Eaton Myasthenic Syndrome Treated With Subcutaneous Immunoglobulin: A Case Report and Review of Literature.
    Park SK; Taylor MG
    Cureus; 2024 May; 16(5):e60773. PubMed ID: 38903354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcium channel autoantibodies in myasthenic syndrome and small cell lung cancer.
    Pelucchi A; Ciceri E; Clementi F; Marazzini L; Foresi A; Sher E
    Am Rev Respir Dis; 1993 May; 147(5):1229-32. PubMed ID: 8387255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies to calcium channel and synaptotagmin in Lambert-Eaton myasthenic syndrome.
    Takamori M; Komai K; Iwasa K
    Am J Med Sci; 2000 Apr; 319(4):204-8. PubMed ID: 10768604
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Molecular immunology of voltage-gated calcium channel and Lambert-Eaton myasthenic syndrome].
    Iwasa K; Komai K; Yasukawa Y; Maruta T; Takamori M
    Nihon Rinsho; 1997 Dec; 55(12):3322-30. PubMed ID: 9436458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective study into the incidence of Lambert Eaton myasthenic syndrome in small cell lung cancer.
    Payne M; Bradbury P; Lang B; Vincent A; Han C; Newsom-Davis J; Talbot D
    J Thorac Oncol; 2010 Jan; 5(1):34-8. PubMed ID: 19934775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lambert-Eaton myasthenic syndrome.
    Newsom-Davis J
    Rev Neurol (Paris); 2004 Feb; 160(2):177-80. PubMed ID: 15034474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.